title: [Effect of qi benefiting stasis removing method on systemic inflammatory response and coagulation function in MODS patients].
abstract: OBJECTIVE
  To observe the effect of qi benefiting stasis removing method (QBSRM) on systemic inflammatory response and coagulation function in multiple organ dysfunction syndrome (MODS) patients.
  
  
  METHODS
  Totally 40 MODS patients who were admitted to Affiliated Hospital of Nanjing University of Traditional Chinese Medicine between May 2010 to December 2011 were randomly assigned to two groups, the experimental group (21 cases) and the control group (19 cases). Patients in the control group were treated with routine Western therapy, while those in the experimental group additionally took decoction for benefiting qi removing stasis. Inflammatory factors (including interleukin-1, interleukin-6, tumor necrosis factor-alpha) and coagulation parameters [including prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), and D-dimer (DD)] were observed before treatment, and 3, 7, and 14 days after treatment in the two groups.
  
  
  RESULTS
  At day 7 after treatment,levels of interleukin-1, interleukin-6, and PT were significantly lower in the experimental group than in the control group (P < 0.05). At day 14 after treatment, tumor necrosis factor-x and DD were significantly lower in the experimental group than in the control group (P < 0. 05). There was no statistical difference in APTT or FIB at day 3, 7 and 14 after treatment (P > 0.05).
  
  
  CONCLUSIONS
  QBSRM could relieve systemic inflammatory response and improve coagulation functions.
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Jun
authors: J
authors: Lu
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Ming-Qi
authors: MQ
authors: Chen
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Yan-Xia
authors: YX
authors: Geng
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Lu
authors: L
authors: Cheng
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Hai
authors: H
authors: Lu
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Hua
authors: H
authors: Jiang
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Jiang
authors: J
authors: Zhou
authors: Intensive Care Unit, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.
authors: Xing
authors: X
authors: Wang
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001777:Blood Coagulation; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007249:Inflammation; D007375:Interleukin-1 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D008517:Phytotherapy
chemical_list: D004365:Drugs, Chinese Herbal; D007375:Interleukin-1; D015850:Interleukin-6